See the difference! Customize Seeking Alpha:
Sign in or join
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
Santarus Inc. (SNTS)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: SNTS
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Top Authors
Most frequent coverage on SNTS
Mike Havrilla
(1966 followers)
Extreme FDA Trades: 30 Stocks Under 5 Bucks
(Sun, Aug 2)
FDA Extreme Trades: 16 Stocks Under 5 Bucks
(Sun, Jun 28)
FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS
(Tue, Jun 23)
More by Mike Havrilla on SNTS »
R. Saito
(29 followers)
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
(Fri, Nov 20)
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
(Mon, Nov 16)
More by R. Saito on SNTS »
SA Editor Miriam Metzinger
(562 followers)
Jim Cramer's Mad Money In-Depth Stock Picks, Oct. 19
(Fri, Oct 20)
More by SA Editor Miriam Metzinger on SNTS »
Most followed authors on SNTS
Mike Havrilla
(1966 followers)
Extreme FDA Trades: 30 Stocks Under 5 Bucks
(Sun, Aug 2)
FDA Extreme Trades: 16 Stocks Under 5 Bucks
(Sun, Jun 28)
FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS
(Tue, Jun 23)
More by Mike Havrilla on SNTS »
Zacks.com
(1115 followers)
Santarus: Business Fundamentals Improving
(Sun, Jun 21)
More by Zacks.com on SNTS »
J Clinton Hill
(981 followers)
Three Top and Bottom Market Sectors for This Week
(Sun, Jun 21)
More by J Clinton Hill on SNTS »
Newest authors on SNTS
R. Saito
(29 followers)
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
(Fri, Nov 20)
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
(Mon, Nov 16)
More by R. Saito on SNTS »
ThreeBrothersHealth.com
(14 followers)
Santarus: Business Fundamentals Are Unchanged
(Wed, Jun 24)
More by ThreeBrothersHealth.com on SNTS »
Michael Becker
(176 followers)
Biotech’s 2009 Stealth Small Cap Rally
(Mon, Jan 4)
More by Michael Becker on SNTS »
Most commented on SNTS
Mike Havrilla
(1966 followers)
Extreme FDA Trades: 30 Stocks Under 5 Bucks
(Sun, Aug 2)
FDA Extreme Trades: 16 Stocks Under 5 Bucks
(Sun, Jun 28)
FDA Calendar Updates: ACUR, BSX, JAV, KG, SNTS
(Tue, Jun 23)
More by Mike Havrilla on SNTS »
Zacks.com
(1115 followers)
Santarus: Business Fundamentals Improving
(Sun, Jun 21)
More by Zacks.com on SNTS »
R. Saito
(29 followers)
Santarus' Zegrid Facing Back-to-Back FDA Approval Dates
(Fri, Nov 20)
Santarus, Depomed Poised to Gain from Anticipated Sales of Glumetza
(Mon, Nov 16)
More by R. Saito on SNTS »